Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06595654
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-24
Brief Title:
Treatment of Negative Symptoms of Schizophrenia by rTMS
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Treatment of Negative Symptoms of Schizophrenia by Repetitive Transcranial Magnetic Stimulation A Naturalistic Study
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SN RENAT
Brief Summary:
The purpose of this study is to assess the effectiveness of rTMS on the negative symptoms of schizophrenia in real conditions It will also provide a regulatory framework to rTMS treatments under these conditions 4 types of rTMS protocols are proposed allowing to adapt to patients and their tolerancesTreatment lasts between 2 and 4 weeks with a follow-up period of 3 months after treatment to observe relapsesTo assess the evolution of negative symptoms between baseline and the end of treatment investigators use SANS Scale for the Assessment of Negative Symptoms
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None